Literature DB >> 16563963

Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation.

Matthew E Prekker1, D S Nath, A R Walker, A C Johnson, M I Hertz, C S Herrington, D M Radosevich, Peter S Dahlberg.   

Abstract

BACKGROUND: A scoring system was recently proposed to grade the severity of primary graft dysfunction (PGD), a frequent early complication of lung transplantation. The purposes of this study are to: (1) validate the PGD grading system with respect to patient outcomes; and (2) compare the performance of criteria employing the arterial oxygenation to fraction of inspired oxygen (P/F) ratio to an alternative grading system employing the oxygenation index (OI).
METHODS: We retrospectively reviewed the medical records of 402 patients having undergone lung transplantation at our institution from 1992 through 2004. The ISHLT PGD grading system was modified and grades were assigned up to 48 hours post-transplantation as follows: Grade 1 PGD, P/F > 300; Grade 2, P/F 200 to 300; and Grade 3, P/F < 200. A worst score T(0-48) was also assigned, which reflects the highest grade recorded between T0 and T48.
RESULTS: The prevalence of severe PGD (P/F Grade 3) declined after transplant, from 25% at T0 to 15% at T48. Grouping patients by P/F grade at T48 demonstrated the clearest differentiation of 90-day death rates (Grade 1, 7%; Grade 2, 12%; Grade 3, 33%) (p = 0.0001). T48 OI grade also differentiates 90-day death rates. There was no difference in longer-term survival between patients with PGD Grades 1 and 2. OI grade at T0 qualitatively improved differential mortality between Grades 1 and 2; however, the differences did not reach statistical significance. Patients with a worst score T(0-48) of Grade 3 PGD did have significantly decreased long-term survival, as well as longer ICU and hospital stay, when compared with Grades 1 and 2 PGD. Significant risk factors for short- and long-term mortality in our multivariate model were P/F Grade 3 [worst score T(0-48) as well as T0 grade], single-lung transplant, use of cardiopulmonary bypass and high pre-operative mean pulmonary artery pressure.
CONCLUSIONS: There is an increased risk of short- and long-term mortality and length of hospital stay associated with severe (Grade 3) PGD. The proposed ISHLT grading system can rapidly identify patients with poor outcomes who may benefit from early, aggressive treatment. Refinement of the scoring system may further improve patient risk stratification.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16563963     DOI: 10.1016/j.healun.2005.11.436

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  28 in total

1.  CASE 7--2014 Rescue therapy with early extracorporeal membrane oxygenation for primary graft dysfunction after bilateral lung transplantation.

Authors:  Ali M Farooki; Heidi Bazick-Cuschieri; Emily K Gordon; James C Lee; Edward C Cantu; John G Augoustides
Journal:  J Cardiothorac Vasc Anesth       Date:  2013-08-30       Impact factor: 2.628

2.  Emphysema-associated Autoreactive Antibodies Exacerbate Post-Lung Transplant Ischemia-Reperfusion Injury.

Authors:  Kunal J Patel; Qi Cheng; Sarah Stephenson; D Patterson Allen; Changhai Li; Jane Kilkenny; Ryan Finnegan; Valeria Montalvo-Calero; Scott Esckilsen; Chentha Vasu; Martin Goddard; Satish N Nadig; Carl Atkinson
Journal:  Am J Respir Cell Mol Biol       Date:  2019-06       Impact factor: 6.914

3.  Human recombinant apyrase therapy protects against canine pulmonary ischemia-reperfusion injury.

Authors:  Mohsen Ibrahim; Xingan Wang; Carlos A Puyo; Alessandro Montecalvo; Howard J Huang; Ramsey R Hachem; Claudio Andreetti; Cecilia Menna; Ridong Chen; Alexander S Krupnick; Daniel Kreisel; Erino A Rendina; Andrew E Gelman
Journal:  J Heart Lung Transplant       Date:  2014-10-02       Impact factor: 10.247

Review 4.  Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.

Authors:  S Samuel Weigt; Ariss DerHovanessian; W Dean Wallace; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2013-07-02       Impact factor: 3.119

5.  Influence of donor-recipient gender mismatch on graft function and survival following lung transplantation.

Authors:  Antonio Alvarez; Paula Moreno; Jennifer Illana; Dionisio Espinosa; Carlos Baamonde; Elisabet Arango; Francisco Javier Algar; Angel Salvatierra
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-01-15

6.  Preoperative echocardiographic-defined moderate-severe pulmonary hypertension predicts prolonged duration of mechanical ventilation following lung transplantation for patients with COPD.

Authors:  Jeremy P Wrobel; Bruce R Thompson; Gregory I Snell; Trevor J Williams
Journal:  Lung       Date:  2012-10-12       Impact factor: 2.584

7.  Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome.

Authors:  H J Huang; R D Yusen; B F Meyers; M J Walter; T Mohanakumar; G A Patterson; E P Trulock; R R Hachem
Journal:  Am J Transplant       Date:  2008-09-10       Impact factor: 8.086

8.  Reduced Cerebral Perfusion Pressure during Lung Transplant Surgery Is Associated with Risk, Duration, and Severity of Postoperative Delirium.

Authors:  Patrick J Smith; James A Blumenthal; Benson M Hoffman; Sarah K Rivelli; Scott M Palmer; Robert D Davis; Joseph P Mathew
Journal:  Ann Am Thorac Soc       Date:  2016-02

Review 9.  Primary Graft Dysfunction after Lung Transplantation.

Authors:  Gülbin Töre Altun; Mustafa Kemal Arslantaş; İsmail Cinel
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-12-01

10.  Increased Intraoperative Fluid Administration Is Associated with Severe Primary Graft Dysfunction After Lung Transplantation.

Authors:  Mariya A Geube; Silvia E Perez-Protto; Tory L McGrath; Dongsheng Yang; Daniel I Sessler; Marie M Budev; Andrea Kurz; Kenneth R McCurry; Andra E Duncan
Journal:  Anesth Analg       Date:  2016-04       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.